A detailed history of Manchester Financial Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Manchester Financial Inc holds 3,791 shares of MRK stock, worth $390,927. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,791
Previous 3,770 0.56%
Holding current value
$390,927
Previous $466,000 7.73%
% of portfolio
0.1%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$111.15 - $128.97 $2,334 - $2,708
21 Added 0.56%
3,791 $430,000
Q2 2024

Jul 17, 2024

BUY
$123.8 - $132.96 $18,570 - $19,944
150 Added 4.14%
3,770 $466,000
Q1 2024

Apr 18, 2024

BUY
$113.24 - $131.95 $22,421 - $26,126
198 Added 5.79%
3,620 $477,000
Q2 2023

Jul 28, 2023

BUY
$108.61 - $118.38 $1,086 - $1,183
10 Added 0.29%
3,422 $394,000
Q1 2023

Apr 19, 2023

SELL
$102.94 - $114.86 $3,397 - $3,790
-33 Reduced 0.96%
3,412 $363,000
Q4 2022

Feb 08, 2023

SELL
$87.44 - $112.11 $43,720 - $56,055
-500 Reduced 12.67%
3,445 $382,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $90,616 - $101,797
1,072 Added 37.31%
3,945 $340,000
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $239,866 - $271,900
2,873 New
2,873 $262,000
Q2 2021

Jul 21, 2021

SELL
$70.31 - $77.77 $87,676 - $96,979
-1,247 Closed
0 $0
Q1 2021

May 03, 2021

BUY
$68.86 - $81.11 $10,604 - $12,490
154 Added 14.09%
1,247 $96,000
Q1 2020

Apr 20, 2020

SELL
$63.36 - $87.82 $7,983 - $11,065
-126 Reduced 10.34%
1,093 $84,000
Q4 2019

Jan 17, 2020

BUY
$77.58 - $87.54 $94,570 - $106,711
1,219 New
1,219 $111,000
Q3 2019

Oct 09, 2019

SELL
$76.08 - $82.93 $92,741 - $101,091
-1,219 Closed
0 $0
Q2 2019

Jul 23, 2019

BUY
$69.84 - $81.59 $85,134 - $99,458
1,219 New
1,219 $102,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Manchester Financial Inc Portfolio

Follow Manchester Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Financial Inc with notifications on news.